Prävention atherothrombotischer Ereignisse: CHARISMA-Studie (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance)

Author： Erdmann E.  

Publisher： Springer Publishing Company

ISSN： 0020-9554

Source： Der Internist, Vol.47, Iss.12, 2006-12, pp. : 1295-1297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Detection and Management of Associated Atherothrombotic Locations in Patients with a Recent Atherothrombotic Ischemic Stroke: Results of the DETECT Survey

By  

Cerebrovascular Diseases, Vol. 21, Iss. 1-2, 2006-01 ,pp. : 60-66

Karger

Access to resources Recommend Favorite

Atorvastatin zur Primärprävention kardiovaskulärer Ereignisse: ASCOT-LLA-Studie

By März W.  

Der Internist, Vol. 45, Iss. 3, 2004-03 ,pp. : 355-357

Springer Publishing Company

Access to resources Recommend Favorite

Management of Atherothrombosis with Clopidogrel in High-Risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke (MATCH): Study Design and Baseline Data

By  

Cerebrovascular Diseases, Vol. 17, Iss. 2-3, 2003-12 ,pp. : 253-261

Karger

Access to resources Recommend Favorite

An Epidemiologic Reassessment of Lipoprotein(a) and Atherothrombotic Risk

By Ridker P.M.  

Trends in Cardiovascular Medicine, Vol. 5, Iss. 6, 1995-11 ,pp. : 225-229

Elsevier

Access to resources Recommend Favorite

From CURE to MATCH: ADP Receptor Antagonists as the Treatment of Choice for High-Risk Atherothrombotic Patients

By  

Cerebrovascular Diseases, Vol. 13, Iss. 1, 2002-01 ,pp. : 22-26

Karger

Access to resources Recommend Favorite